JEANNA BERKEY: Open Payments
NPI 1891400578 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 16 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $243 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $136 |
| ABBVIE INC. | 2 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Averitas Pharma Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: QULIPTA, Wegovy, Kerendia, JARDIANCE, QUTENZA, SPRAVATO, GVOKE HYPOPEN, LINZESS.
Industry payments across MS — which companies pay providers there.
